Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis

NCT01050777 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Leishmaniasis

Interventions

DRUG: Liposomal meglumine antimoniate (Glucantime)
DRUG: Liposomal meglumine antimoniate
DRUG: Liposomal Paromomycin
DRUG: Placebo

Sponsor

Tehran University of Medical Sciences

Collaborators

[object Object]
[object Object]